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Introductory Remarks. I
WILLIAM T. FRIEDEWALD, MD
National Heart, Lung, and Blood Institute, National Institutes
of Health
I speak on behalf of the National Heart, Lung, and Blood
Institute (NHLBI) when I say we are delighted to be a
cosponsor for this important and timely Bethesda Confer-
ence. As we have learned more about the problems of car-
diovascular disease in the elderly, the issues have become
more critical and now reflect an area of special research
interest for the NHLBI. The National Center for Health
Statistics (NCHS) estimated that in 1984 there were ap-
proximately 26 million people in the United States aged
::::65 years and living independently, that is, outside nursing
homes or other similar facilities. Eight percent of this elderly
population were black. Most were women; 59% in the age
group 65 to 74 years and up to 71% in the age group ::::85
years were women. In addition, the size of our elderly
population is growing dramatically, with an estimated in-
crease of 20% during the next decade alone.
Currently, more than half of the patients in hospitals each
year who are diagnosed as having an acute myocardial in-
farction are ::::65 years of age. This fraction can be expected
to increase significantly during the 1990s. Even though over-
all coronary heart disease mortality rates in the United States
declined dramatically during the 1970s, the rates for those
aged >65 years have not shown the high rates of decline
observed for younger members of our society.
NHLBI-sponsored and cosponsored programs such as the
Systolic Hypertension in the Elderly Program, the Beta-
blocker Heart Attack Trial, the Framingham Heart Study
and the Coronary Artery Surgery Study all relate to the
important topic of this conference. More directly relevant,
however, is a working conference held last September by
the NHLBI on the topic of Recognition and Management
of Coronary Heart Disease in the Elderly (I). That confer-
ence came to several important conclusions and recom-
mendations. Briefly, it was felt that, although the U.S.
population aged ::::65 years encompasses the majority of
patients with coronary heart disease, scientific information
regarding the recognition of and current treatment ap-
proaches to the elderly coronary patient is inadequate or
lacking. It was also considered inappropriate to uncritically
extrapolate information obtained from younger persons to
an elderly population, who as a group are remarkably het-
erogeneous with regard to their health and life-style char-
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acteristics. The elderly are likely to be at increased risk for
complications associated with various diagnostic and ther-
apeutic procedures and often, appropriately, have quite dif-
ferent expectations concerning the outcomes of their illness.
It was also felt that more basic health information, including
data on prevention, diagnosis and treatment of coronary
heart disease, was needed about this rapidly increasing seg-
ment of our society.
Additional issues raised at that NHLBI conference were:
whether the traditional risk factors for coronary heart disease
determined in younger populations have similar predictive
power in the elderly; whether nutritional and exercise guide-
lines should differ from those for younger people; whether
the benefit conveyed by drugs used to treat coronary heart
disease are of similar value in the aged as in the young;
whether the quality of life is not more important than the
additional length of life in the elderly; and whether one can
or should justify upper age limits for such therapeutic pro-
cedures as coronary bypass surgery or percutaneous trans-
luminal coronary angioplasty, or for various preventive ap-
proaches appropriate with younger populations. As a
consequence of this working conference, as well as related
activities, the NHLBI sees a continuing need to initiate and
support research in coronary heart disease in the elderly.
We now look forward with excitement and interest to the
deliberations and recommendations of this broader scope
Bethesda Conference.
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Introductory Remarks. II
LOT B. PAGE, MD
National Institute on AKinK. National Institutes of Health
I am happy to greet you on behalf of the National Institute
on Aging and its Director, Dr. T. Franklin Williams. It is
very appropriate and timely that "Cardiovascular Disease
in the Elderly" is the subject of this year's Bethesda Con-
ference. The United States, and indeed the entire industrial-
ized world, is experiencing a demographic explosion in the
upper decades of age. The rapid current increase in numbers
of older persons in society is unprecedented in history and
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